Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Pia Adorni

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Journal of Clinical Medicine|July 12, 2020
Anti-atherogenic Modification of Serum Lipoprotein Function in Patients with Rheumatoid Arthritis after Tocilizumab Treatment, a Pilot StudyDaniela Greco, Roberta Gualtierotti, Pasquale Agosti, et al.
RMD Open|September 16, 2022
Serum cholesterol loading capacity on macrophages is linked to coronary atherosclerosis and cardiovascular event risk in rheumatoid arthritisGeorge Athanasios Karpouzas, Bianca Papotti, Sarah Ormseth, et al.
Cardiovascular Research|July 2, 2013
Inflammation impairs eNOS activation by HDL in patients with acute coronary syndromeMonica Gomaraschi, Alice Ossoli, Elda Favari, et al.
Atherosclerosis|August 21, 2015
Cholesterol trafficking-related serum lipoprotein functions in children with cholesteryl ester storage diseaseFrancesca Zimetti, Elda Favari, Paola Cagliero, et al.
Atherosclerosis|April 9, 2021
The effect of transgender hormonal treatment on high density lipoprotein cholesterol efflux capacityDaan M van Velzen, Maria Pia Adorni, Francesca Zimetti, et al.
Journal of Lipid Research|October 30, 2012
ABCA1-dependent serum cholesterol efflux capacity inversely correlates with pulse wave velocity in healthy subjectsElda Favari, Nicoletta Ronda, Maria Pia Adorni, et al.
Journal of Autoimmunity|March 30, 2023
ATP-binding cassette G1 membrane transporter-mediated cholesterol efflux capacity influences coronary atherosclerosis and cardiovascular risk in Rheumatoid ArthritisGeorge A Karpouzas, Bianca Papotti, Sarah R Ormseth, et al.
Journal of Translational Autoimmunity|July 31, 2023
Inflammation and immunomodulatory therapies influence the relationship between ATP-binding cassette A1 membrane transporter-mediated cholesterol efflux capacity and coronary atherosclerosis in rheumatoid arthritisGeorge A Karpouzas, Bianca Papotti, Sarah R Ormseth, et al.
Journal of Translational Autoimmunity|July 24, 2023
Statins influence the relationship between ATP-binding cassette A1 membrane transporter-mediated cholesterol efflux capacity and coronary atherosclerosis in rheumatoid arthritisGeorge A Karpouzas, Bianca Papotti, Sarah R Ormseth, et al.
Annals of the Rheumatic Diseases|April 9, 2013
Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosusNicoletta Ronda, Elda Favari, Maria Orietta Borghi, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Journal of Clinical Medicine|July 12, 2020
Anti-atherogenic Modification of Serum Lipoprotein Function in Patients with Rheumatoid Arthritis after Tocilizumab Treatment, a Pilot StudyDaniela Greco, Roberta Gualtierotti, Pasquale Agosti, et al.
RMD Open|September 16, 2022
Serum cholesterol loading capacity on macrophages is linked to coronary atherosclerosis and cardiovascular event risk in rheumatoid arthritisGeorge Athanasios Karpouzas, Bianca Papotti, Sarah Ormseth, et al.
Cardiovascular Research|July 2, 2013
Inflammation impairs eNOS activation by HDL in patients with acute coronary syndromeMonica Gomaraschi, Alice Ossoli, Elda Favari, et al.
Atherosclerosis|August 21, 2015
Cholesterol trafficking-related serum lipoprotein functions in children with cholesteryl ester storage diseaseFrancesca Zimetti, Elda Favari, Paola Cagliero, et al.
Atherosclerosis|April 9, 2021
The effect of transgender hormonal treatment on high density lipoprotein cholesterol efflux capacityDaan M van Velzen, Maria Pia Adorni, Francesca Zimetti, et al.
Journal of Lipid Research|October 30, 2012
ABCA1-dependent serum cholesterol efflux capacity inversely correlates with pulse wave velocity in healthy subjectsElda Favari, Nicoletta Ronda, Maria Pia Adorni, et al.
Journal of Autoimmunity|March 30, 2023
ATP-binding cassette G1 membrane transporter-mediated cholesterol efflux capacity influences coronary atherosclerosis and cardiovascular risk in Rheumatoid ArthritisGeorge A Karpouzas, Bianca Papotti, Sarah R Ormseth, et al.
Journal of Translational Autoimmunity|July 31, 2023
Inflammation and immunomodulatory therapies influence the relationship between ATP-binding cassette A1 membrane transporter-mediated cholesterol efflux capacity and coronary atherosclerosis in rheumatoid arthritisGeorge A Karpouzas, Bianca Papotti, Sarah R Ormseth, et al.
Journal of Translational Autoimmunity|July 24, 2023
Statins influence the relationship between ATP-binding cassette A1 membrane transporter-mediated cholesterol efflux capacity and coronary atherosclerosis in rheumatoid arthritisGeorge A Karpouzas, Bianca Papotti, Sarah R Ormseth, et al.
Annals of the Rheumatic Diseases|April 9, 2013
Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosusNicoletta Ronda, Elda Favari, Maria Orietta Borghi, et al.
Pageof 7